Israeli startup Sweetch leverages AI for diabetes prevention
Earlier this year, the company, which raised $3.5 million in 2016, revealed the findings of a three-month study of its technology conducted at Johns Hopkins University.
Earlier this year, the company, which raised $3.5 million in 2016, revealed the findings of a three-month study of its technology conducted at Johns Hopkins University.
A little more than one year after OurCrowd Qure launched a digital health fund and Luminox Health partnered with Johns Hopkins to validate medtech, a managing partner of the fund and CEO of Luminox, Dr. Yossi Bahagon, offered an update in response to emailed questions.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In the latest startup to join the war against diabetes, Sweetch has raised $3.5 million in a Series A round led by equity crowdfunding platform OurCrowd and Philips, according to the website, NoCamels. The company is focused not on people who have been diagnosed with the chronic condition, but for those who are at risk […]